| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID893 |
| PMID | 19795908 |
| Peptide Sequence | EELQFSLGSKI |
| Peptide Sequence in Publication | EELQFSLGSKI |
| Protein Name | Complement C4-B |
| UniprotKB Entry Name | CO4B_HUMAN |
| Biofluid | Plasma |
| M/Z | 625.83 |
| Charge | 2 |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | LC-MS |
| Peptide Identification Technique | MALDI-TOF/TOF |
| Quantification Technique | LC-MRM (multiple reaction monitoring) |
| Labeling | Labelled |
| FDR | less than 7% |
| p-Value | NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software |
| Length of Peptide | 11 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP) |
| Database for Peptide search | NCBI refseq Protein Database |
| Modification | NA |
| Number of Patients | "42 normal, 28 patients" |
| Regulation/Differential Expression | NA |
| Validation | NA |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | 462023
|